Blog Topic: Oncology

• 

  A Widespread Virus May Open the Door to a New Targeted Therapy for Head and Neck Cancers

  December 19, 2023

  Ahmed Diab, PhD, has been researching the relationship of HPV and the WEE1 kinase checkpoint in head and neck cancers.

  Otorhinolaryngology ENT Oncology
• 

  Connections: Sisterhood and Friendship Make a Difference in Genetic Research

  November 16, 2023

  Laura Friedman and Fran Jaskot, sisters with RVCL, a rare genetic disease, will be honored by a Run/Walk November 18th, in Bethesda, MD.

  Oncology
• 

  Dr. Robert Vonderheide Presents for NCI Division of Cancer Prevention

  September 06, 2023

  Director of the Abramson Cancer Center, Dr. Robert Vonderheide will be discussing Opportunities for Cancer Immune Health, Prevention, and Interception for the NCI Division of Cancer Prevention on September 13th at 1:00 PM ET.

  Oncology
• 

  Uncommon Measures for an Uncommon Cancer: Management of Retroperitoneal Sarcoma at Penn Medicine's Abramson Cancer Center

  May 22, 2023

  The Penn Medicine Sarcoma Program offers a multidisciplinary approach to patients with retroperitoneal sarcoma, among the rarest of cancers.

  Oncology
• 

  Improving Access to Orthopaedic Surgery, for Providers and Patients Alike

  November 17, 2022

  Cara Cipriano, MD, MSc, is engaging medical students to reverse preconceived notions and create a more inclusive presence in the field of orthopaedics, as well as improving accessibility for patients.

  Orthopaedics and Sports Medicine Oncology
• 

  Chimeric Antigen Receptor Macrophage (CAR-M) Therapy for HER2 Overexpressing Solid Tumors

  April 29, 2022

  Penn Medicine is one of five sites participating in a first-in-human Phase 1 study evaluating the potential of CAR M cell therapy in recurrent or metastatic HER2-overexpressing solid tumors.

  Immunotherapy Oncology
• 

  CAR T Cell Therapy for Medullary Thyroid Cancer Trial Now Enrolling at the Abramson Cancer Center

  February 17, 2022

  Drs. Roger Cohen and Donald Siegel are conducting an enrolling clinical trial at Penn for a novel CAR T therapy for medullary thyroid cancer.

  Oncology Immunotherapy
• 

  Surveillance and Management for the Heritable GI Cancers at Penn Gastroenterology

  December 27, 2021

  The Penn GI Cancer Genetics Program is at the nexus of treatment and genetic research for inherited GI cancers, including the heritable colorectal cancer and polyposis syndromes.

  Gastroenterology, Hepatology and GI Surgery Oncology
• 

  An Unprecedented Year Sees Unprecedented Expansion in Physician Leadership at Penn Medicine

  December 16, 2021

  Welcoming six new physician leaders to Penn Medicine

  Neurology Otorhinolaryngology ENT Surgery
• 

  At Penn Medicine, an Impactful Transformation in Cancer Leadership

  December 03, 2021

  Meet five new physician leaders at the forefront of cancer care at Penn Medicine.

  Urology Surgery Neurosurgery